Project Details
| Status | Active |
|---|---|
| Effective start/end date | 12/02/19 → 11/02/24 |
An International, Multicenter, Openlabel, Randomized, Phase 3 Study of BLU285 vs Regorafenib in Patients with Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
- Segelov, Eva (Primary Chief Investigator (PCI))
Project: Research